BOIMMG

1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

BOIMMG ID - 271499

Name - 1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC/C=C\CCCCCCCC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O

InChIKey - ZXHLTJHCYTUDHM-LKKLCQSDSA-G

Formula - C69H117O22P4

Annotated - ✔

SWISS LIPIDS id - SLM:000440971

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4,5-bisphosphate	C69H118O19P3	292020	✔
1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C69H119O16P2	281376	✔
1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C69H120O13P	26276	✔
CDP-1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycerol	C72H121N3O15P2	558393	✔
1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C69H119O16P2	270002	✔
1-(17Z-hexacosenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phosphate	C63H109O8P	21050	✔
Acyl-ACP ((16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoate)	C34H55OSR1	749010	✗
1-(17Z-hexacosenoyl)-sn-glycero-3-phosphate	C29H55O7P	6825	✔
(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoyl-CoA	C55H86N7O17P3S	393	✔
Acyl-ACP ((17Z)-hexacosenoate)	C26H49OSR1	749019	✗
Acyl-Phosphates ((17Z)-hexacosenoate)	C26H51O5P	737679	✗